SLT Holdings
ABBV icon

SLT Holdings’s AbbVie ABBV Stock Holding History

SLT Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$336K Sell
1,285
-3,324
-72% -$852K 0.2% 105
2026
Q2 		$1.16M Buy
4,609
+487
+12% +$105K 0.71% 37
2026
Q1 		$896K Buy
4,122
+2,524
+158% +$560K 0.61% 36
2025
Q4 		$365K Hold
1,598
– – 0.23% 89
2025
Q3 		$370K Hold
1,598
– – 0.24% 86
2025
Q2 		$297K Buy
1,598
+273
+21% +$50.7K 0.22% 78
2025
Q1 		$278K Buy
1,325
+15
+1% +$2.92K 0.26% 58
2024
Q4 		$233K Buy
+1,310
New +$241K 0.22% 63

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

SLT Holdings's ABBV Position: Q3 2026 in Review

SLT Holdings reduced its AbbVie (ABBV) stake by 72% in Q3 2026, selling an estimated $852K and leaving 1,285 shares worth $336K. The position accounts for 0.2% of the portfolio, ranked #105.

SLT Holdings first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.16M in Q2 2026. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • SLT Holdings held 1,285 shares of AbbVie worth $336K as of Q3 2026.
  • SLT Holdings sold 3,324 AbbVie shares in Q3 2026, an estimated $852K.
  • AbbVie made up 0.2% of SLT Holdings's portfolio in Q3 2026, its #105 holding.
  • SLT Holdings first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • SLT Holdings's AbbVie position peaked at $1.16M in Q2 2026.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on SLT Holdings's 13F filing for Q3 2026, filed 15 Oct 2026.